Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Charles River Laboratories logoCharles River Laboratories CRL

The company said revenue for Q2 2024 (ended June 29, 2024) was $1.03 billion, down 3.2% from $1.06 billion in Q2 2023. Excluding the effects of foreign currency, divestitures and acquisitions, organic revenue also fell 3.2%.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said revenue for Q2 2024 (ended June 29, 2024) was $1.03 billion, down 3.2% from $1.06 billion in Q2 2023. Excluding the effects of foreign currency, divestitures and acquisitions, organic revenue also fell 3.2%.

  2. Charles River said GAAP diluted earnings per share for Q2 were $1.74, down 7.9% from $1.89 a year earlier, while non-GAAP diluted earnings per share were $2.80, up 4.1%. The company cited lower performance-based compensation accruals and higher revenue and operating income in its Manufacturing segment as drivers of the non-GAAP increase.

  3. The company revised its full-year 2024 outlook, now giving a GAAP EPS estimate of $5.65 to $5.95 (previously $7.60 to $8.10) and a non-GAAP EPS estimate of $9.90 to $10.20 (previously $10.90 to $11.40). Reported revenue is now expected to decline 4.5% to 2.5%, compared with the prior outlook of growth of 1.0% to 4.0%.

  4. The company said its Board of Directors approved a new stock repurchase authorization of $1.0 billion. It replaces a prior authorization under which $129.1 million remained when it was terminated $1.3 billion.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Revenue for Q2 $1.03 billion, down 3.2% Year over Year

The company said revenue for Q2 2024 (ended June 29, 2024) was $1.03 billion, down 3.2% from $1.06 billion in Q2 2023. Excluding the effects of foreign currency, divestitures and acquisitions, organic revenue also fell 3.2%.

Source · Based on the filing body and exhibits

GAAP EPS $1.74, Non-GAAP EPS $2.80

Charles River said GAAP diluted earnings per share for Q2 were $1.74, down 7.9% from $1.89 a year earlier, while non-GAAP diluted earnings per share were $2.80, up 4.1%. The company cited lower performance-based compensation accruals and higher revenue and operating income in its Manufacturing segment as drivers of the non-GAAP increase.

Source · Based on the filing body and exhibits

Revises 2024 Guidance

The company revised its full-year 2024 outlook, now giving a GAAP EPS estimate of $5.65 to $5.95 (previously $7.60 to $8.10) and a non-GAAP EPS estimate of $9.90 to $10.20 (previously $10.90 to $11.40). Reported revenue is now expected to decline 4.5% to 2.5%, compared with the prior outlook of growth of 1.0% to 4.0%.

Source · Based on the filing body and exhibits

$1.0 billion New Stock Repurchase Authorization

The company said its Board of Directors approved a new stock repurchase authorization of $1.0 billion. It replaces a prior authorization under which $129.1 million remained when it was terminated $1.3 billion.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.